![1]()
News
Thirty-second atrial fib threshold may drive overdiagnosis
May 10, 2018
BOSTON – The current 30-second threshold for defining clinically meaningful AF “metastasized” from a select subgroup of patients to all AF settings.
![1]()
News
First reversal agent for apixaban and rivaroxaban gets fast-track approval
May 4, 2018
Andexanet alfa approval puts factor Xa inhibitors in the same ballpark as dabigatran, reversible with idarucizumab.
![1]()
News
Lower glucose target linked to improved mortality in critically ill
May 3, 2018
The findings of a new study of critically ill patients challenge current guidelines on the use of intensive insulin therapy.
![1]()
News
Does warfarin cause acute kidney injury?
May 2, 2018
SAN DIEGO – Consider increased monitoring of renal function in certain patients.
![1]()
News
How should asymptomatic hypertension be managed in the hospital?
May 1, 2018
The appropriate treatment of hypertension in the inpatient setting is suboptimal due to the lack of guidelines and inconsistent management.
![1]()
News
Noninvasive cardiac testing to rule out acute coronary syndromes provides no benefit in low-risk chest pain patients
April 27, 2018
Does clinical evaluation and noninvasive cardiac testing improve outcomes in patients who present to the emergency department (ED) with acute chest pain, compared with clinical evaluation alone?
![1]()
News
Lower risk of ICH with dabigatran as compared to warfarin in atrial fibrillation
April 26, 2018
Is dabigatran superior to warfarin with regards to the risk of intracranial hemorrhage and myocardial infarction in patients with atrial fibrillation?
![1]()
News
Impaired kidney function no problem for dabigatran reversal
April 23, 2018
ORLANDO – Idarucizumab, reversal agent for the anticoagulant dabigatran, worked fine in patients with renal dysfunction.
![1]()
News
24-hour ambulatory BP measurements strongly predict mortality
April 18, 2018
Masked hypertension identified by 24-hour monitoring carried the greatest risk of death.
![1]()
News
High 5-year mortality in patients admitted with heart failure regardless of ejection fraction
April 18, 2018
Are there differences in 5-year outcomes in patients hospitalized with heart failure with preserved ejection fraction (ejection fraction [EF], greater than or equal to 50%), heart failure with borderline ejection fraction (EF, 41%-49%), or heart failure with reduced ejection fraction (EF, less than or equal to 40%)?
